Investors Ride 5 Earnings Rollercoaster Rides Including Integra Lifesciences Holdings

Integra LifeSciences Holdings Corporation (NASDAQ:IART) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 18.92% to $0.60 in the quarter versus EPS of $0.74 in the year-earlier quarter. Revenue Decreased 2.22% to $205.5 million from the year-earlier quarter.

Integra LifeSciences Holdings Corporation reported adjusted EPS income of $0.60 per share. By that measure, the company beat the mean analyst estimate of $0.55. It missed the average revenue estimate of $207.3 million.

IART 20130803

Incyte Corporation (NASDAQ:INCY) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 66.67% to $0.05 in the quarter versus EPS of $0.03 in the year-earlier quarter. Revenue Rose 17.52% to $101.7 million from the year-earlier quarter.

Incyte Corporation reported adjusted EPS income of $0.05 per share. By that measure, the company missed the mean analyst estimate of $0.08. It missed the average revenue estimate of $114.34 million.

INCY 20130803

Ligand Pharmaceuticals (NASDAQ:LGND) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.07 in the quarter versus EPS of $-0.11 in the year-earlier quarter. Revenue Rose 66.9% to $9.58 million from the year-earlier quarter.

Ligand Pharmaceuticals reported adjusted EPS income of $0.07 per share. By that measure, the company beat the mean analyst estimate of $0.05. It beat the average revenue estimate of $9.3 million.

LGND 20130803

Masimo Corporation (NASDAQ:MASI) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share were the same at $0.30 in the quarter as EPS of $0.30 in the year-earlier quarter. Revenue Rose 11.92% to $137.42 million from the year-earlier quarter.

Masimo Corporation reported adjusted EPS income of $0.30 per share. By that measure, the company beat the mean analyst estimate of $0.28. It beat the average revenue estimate of $136.36 million.

MASI 20130803

MedAssets, Inc. (NASDAQ:MDAS) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 7.14% to $0.30 in the quarter versus EPS of $0.28 in the year-earlier quarter. Revenue Rose 4.72% to $170.7 million from the year-earlier quarter.

MedAssets, Inc. reported adjusted EPS income of $0.30 per share. By that measure, the company beat the mean analyst estimate of $0.26. It beat the average revenue estimate of $167.79 million.

MDAS 20130803

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.